Research Grants
Interested in applying?
Email Uli and Brittany to let them know
Funding scheme |
Website & info |
Details |
Min data/ EOI/ etc. |
External due date |
*Dates of currently closed opportunities are indicative only and will be updated as they become available |
||||
CURE Epilepsy |
The CURE Epilepsy Award (2 years / $250,000) reflects CURE Epilepsy’s continued focus on scientific advances that have the potential to truly transform the lives of those affected by epilepsy, with prevention and disease modification as critical goals. Key priority areas for the award include: 1) Basic mechanisms of epilepsy; 2) Acquired epilepsies; 3) Pediatric epilepsies; 4) SUDEP; 5) Treatment-resistant epilepsies; and 6) Sleep & epilepsy. Please refer to the LOI guidelines for an overview of CURE Epilepsy’s priority areas, application instructions, and FAQs. |
LOI 11 Jan 2021 | full application 1 April 2021 if invited | |
Lloyd J. Old STAR Program |
This long-term funding will not be tied to a specific research project, but rather will aim to provide a degree of flexibility and freedom for investigators to explore out-of-the-box and disruptive avenues of research. Candidates selected for this award are expected to be future “stars” in the field of cancer immunology: Scientists Taking Risks. Guidelines & application form: Applicants must belong to one of the following categories as of July 1, 2020:
Interested in applying? Email Uli and Brittany to let them know. |
$1.25 million over 5 years |
|
15 Jan 21 |
Allen Foundation |
Mission:
The connections between diet and health remain a basic and primary priority, and consideration has always been given to projects that benefit nutritional programs in the areas of education, training, and research. Low priority has traditionally been given to proposals that help solve immediate or emergency hunger and malnutrition problems. The foundation does not under any circumstances sponsor professional conferences, seminar tables, discussion panels, or similar events. The foundation welcomes proposals that develop and advance: (1) the inclusion of mandatory courses in nutrition in medical schools; (2) bringing the promise of nutrigenomics or nutritional genomics to realization; and (3) the promotion of environmentally sound, economically viable, socially responsive, and sustainable food and agricultural systems. for information on how to apply see: https://allenfoundation.org/how-to-apply/
Interested in applying? Email Uli and Brittany to let them know. |
15 Jan 21 | ||
MRFF EPCDR Initiative 2020 Childhood Cancer Research Grant Opportunity |
GO4456 GrantConnect: https://www.grants.gov.au/ UQ documents can be found here. the objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that improve our understanding of the aetiology, biology and progression of cancer in children and adolescents.
Interested in applying? Email Uli and Brittany to let them know. |
up to $1.5 million over three years |
internal deadline 13/1/21 Minimum data 20 January 2021 |
3 Feb 2021
|
MRFF Efficient Use of Existing Medicines |
GO4450 on GrantConnect: https://www.grants.gov.au/ More information can be found here. Preventive and Public Health Research Initiative - 2020 Efficient Use of Existing Medicines Grant Opportunity will support Australian medical research projects that conduct clinical trials to address one of the following topics:
Priority will be given to clinical trials investigating changes in the use of medicines that have the greatest potential impact on patients, clinical care and/or health service delivery. The anticipated outcome of the research is to improve the health and wellbeing of Australians through clinical trials that investigate the more efficient and effective use of existing medicines. Interested in applying? Email Uli and Brittany to let them know. |
Min data 20 Jan 2021 | 3 Feb 2021 | |
MRFF Maternal Health and First 2000 Days, Early Childhood, and Exercise and Nutrition Grant Opportunity |
GO4446 on GrantConnect: https://www.grants.gov.au/ More information can be found here. Preventive and Public Health Research Initiative supports research that focuses on one or more of the following priorities: maternal health, early childhood, or exercise and nutrition. The objectives of this grant opportunity are to:
Interested in applying? Email Uli and Brittany to let them know. |
Min data 20 Jan 2021 | 3 Feb 2021 | |
ARC Discovery 22 |
GO3193
on GrantConnect: https://www.grants.gov.au/
UQ guidelines can be found here. Non-medical research only - see ARC policy on medical research. Interested in applying? Email Uli and Brittany to let them know. |
$30,000.00 to $2,500,000.00 for projects up to 5 years |
27 Jan 21 | 24 Feb 21 |
RyR-1 Foundation |
Individual Investigator Research Grant Awards are designed to concentrate research inareas that will have the greatest potential to move towards treatments and cures forRYR-1-related diseases Click here for more information A.Novel therapeutic approaches to RYR-1-related diseases. All approaches will beconsidered, but potential interventions include:a.Gene Editing (e.g., CRISPR/Cas9, Base editing, Prime editing, etc.).b.Gene replacement therapy (viral vectors and non-viral technologies).c.Therapeutic strategies utilizing protein and small-molecule binders.d.Therapeutic strategies utilizing nanotechnology/nanoparticles.e.Development of therapeutic interventions that modify RyR1 receptor activity reduce muscle degradation, and/or increase regenerative capacity of skeletalmuscle. B.Prevalence of RYR-1-Related Diseasesa.The most commonly cited prevalence of RYR-1-related myopathy is 1:90,000,and is based on a study from 10 years ago. This is considered a marked6underestimate of the true prevalence of this disease.b.An updated prevalence study is needed and would exploit data from thenumerous international patient registries/databases Interested in applying? Email Uli and Brittany to let them know. |
up to $100k USD for up to two years | 1 March 2021 | |
MRFF Cardiovascular Health Mission
|
GO4750 on GrantConnect: https://www.grants.gov.au/
More information can be found here.
Cardiovascular Health Grant Opportunity aims to provide grants of financial assistance to support Australian medical research and medical innovation projects that develop novel interventions, treatments and conduct small-scale development projects to establish feasible, evidence-based approaches aimed at improving survivorship and reducing morbidity. Applications to this grant opportunity must propose research that addresses one of the three Streams of research:
Interested in applying? Email Uli and Brittany to let them know. |
|
Minimum data and internal close 17 Feb 2021 |
3 Mar 2021
|
MRFF Genomics Health Futures Mission Grant Opportunity |
GO4560 on GrantConnect: https://www.grants.gov.au/
More information can be found here.
The Medical Research Future Fund (MRFF) Genomics Health Futures Mission’s intent is to improve the lives of Australians by accelerating research that delivers more effective testing, diagnosis and treatment; facilitates the adoption of new interventions; and consolidates Australia’s international leadership in genomics. The objective of the 2020 Genomics Health Futures Mission Grant Opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that:
The intended outcomes of the research funded by this grant opportunity are to improve the health and wellbeing of Australians by:
|
17 Feb 2021 | 3 Mar 2021 | |
MRFF Traumatic Brain Injury Mission |
GO4573 on GrantConnect: https://www.grants.gov.au/
More information can be found here.
Traumatic Brain Injury Mission aims to accelerate Australian Traumatic Brain Injury (TBI) research that develops and delivers innovative and effective treatments that substantially and equitably optimise and improve outcomes for people who experience TBI, in partnership with people with TBI and carers. The objective of the 2020 Traumatic Brain Injury Mission grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that:
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:
Interested in applying? Email Uli and Brittany to let them know. |
17 Feb 2021 | 3 Mar 2021 | |
MRFF Stem Cell Therapies |
GO4571 on GrantConnect: https://www.grants.gov.au/
More information can be found here.
2020 Stem Cell Therapies Grant Opportunity will support stem cell research to deliver innovative, safe and effective treatments through innovative projects that:
Interested in applying? Email Uli and Brittany to let them know. |
17 Feb 2021 | 3 Mar 2021 | |
MRFF International Clinical Trial Collaborations (ICTC) |
GrantConnect: https://www.grants.gov.au/ GO4317 The ICTC will provide support for Australian research teams to conduct clinical trial research in collaboration with international counterparts. Applications to this grant opportunity must propose a single clinical trial that will achieve the following outcomes: promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co ordination of clinical trial site/s in Australia; and provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting. Novel health treatments include new and innovative applications of existing interventions. Interested in applying? Email Uli and Brittany to let them know. |
17 Feb 21 | 3 Mar 2021 | |
MRFF Dementia, Ageing and Aged Care |
GO4569 on GrantConnect: https://www.grants.gov.au/
More information can be found here.
2020 Dementia, Ageing and Aged Care Grant Opportunity will support Australian medical research and medical innovation projects that:
The intended outcomes of the research funded by this grant opportunity is to improve the health and wellbeing of Australians:
Applicants to this grant opportunity must propose research that addresses one of the four Streams of research. An application may be submitted to one of the above four Streams only.
Interested in applying? Email Uli and Brittany to let them know. |
24 Feb 2021 | 10 March 2021 | |
National Foundation for Medical Research NFMRI |
General round: Open nationally across all diseases and conditions affecting humans. Applications that fall within portfolios 2 & 3 only. More information about this grant round, including the EOI form, can be found here. Cystic fibrosis round: Cystic Fibrosis applications that fall within portfolios 1, 2 & 3 (preference for 2 & 3), open nationally. More information about this grant round, including forms, once available, can be found here. |
|
general round open cystic fibrosis round - opens 28 April 21 |
general round: 18 March 21 cystic fibrosis: 16 June 21 |
Brain & Behaviour Research Foundation BBRF |
BBRF Young Investigator Grant The BBRF Young Investigator Grant provides support for the most promising young scientists conducting neurobiological research. Two-year awards up to $70,000, or $35,000 per year are provided to enable promising investigators to either extend research fellowship training or begin careers as independent research faculty. Basic and/or clinical investigators are supported, but research must be relevant to serious brain and behavior disorders such as schizophrenia, mood disorders, anxiety disorders or child and adolescent mental illnesses. The YI Grant is intended to support advanced post-doctoral fellows, instructors and assistant professors (or equivalent). For more information see website. |
up to 2 years; up to US$70 total |
25/3/ 21 | |
Human Frontier Science Program HFSP |
HFSP Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries (see guidelines). Participation of scientists from disciplines outside the traditional life sciences such as biophysics, chemistry, computational biology, computer science, engineering, mathematics, nanoscience or physics is recommended because such collaborations have opened up new approaches for understanding the complex structures and regulatory networks that characterize living organisms, their evolution and interactions. Research grants are provided for teams of scientists from different countries who wish to combine their expertise in innovative approaches to questions that could not be answered by individual laboratories. Preliminary results are not required and applicants are expected to develop new lines of research through the research collaboration. It is understood that such research inherently contains risks and HFSP expects that teams of applicants address the risks and outline mitigation strategies for their research in case of failure and how they intend to achieve their goals. Applications for applied research, including medical research typically funded by national medical research bodies, will be deemed ineligible (see guidelines). Team members should not have collaborated before, they will normally not have published original research together, and the project must be significantly different from their ongoing research. |
The amount paid depends on the number of team members which normally should be 2 - 4. Two members from the same country are acceptable if the team can convince the reviewers that both members are essential. No detailed budget is required
|
Need to get a reference number by 18 March 2021 at latest, at the address https://extranet.hfsp.org/ |
LoI Submission by 30 March 2021 Full applications are invited to be submitted by mid September |
Fight MND
|
IMPACT GrantsIMPACT (IMProving and ACcelerating Translation) Grants support projects focused on one or more of the following key issues contributing to the lack of translation of effective treatments through to clinical trial for MND/ALS:
|
Please note that applicants are limited to one (1) CIA and two (2) Co-CI applications for this grant scheme. | 1 April 2021 | |
AMP |
Tomorrow Fund https://www.ampstomorrowfund.com.au/ Every year, AMP’s Tomorrow Fund offers $1 million in grants to amazing Australians doing great things. Individuals of all ages, walks of life and interests – including scientists, social entrepreneurs, educators, artists, athletes, musicians and more – can apply for grants. Interested in applying? Email Uli and Brittany to let them know. |
up to $100k |
April 2021 TBA |
|
NHMRC Ideas grants |
The expected outcomes are:
The scheme will provide particular opportunities for early and mid-career researchers. It is expected that the CIA will have the scientific leadership and skills to achieve the proposed project aims Interested in applying? Email Uli and Brittany to let them know. |
1-5 years | minimum data 7 April | 5 May 2021 |
Cancer council CCQ accelerating collaborative Research Grants |
Cancer Council Queensland has implemented a new scheme for cancer research funding called the Accelerating Collaborative Cancer Research (ACCR) grants scheme. The ACCR grants scheme has replaced CCQ’s long-running Cancer Research Project Grants scheme. The new funding scheme is intended to:
Up to two ACCR grants will be awarded in 2020 for funding to commence on 1 January 2021. Each grant will:
|
EOI March |
May no date yet for 2021 |
|
US DoD |
Various opportunities open throughout the year. Check here for current opportunities: https://cdmrp.army.mil/funding/prgdefault Some selected funding opportunities from that website are : Breast Cancer Research ProgramBreakthrough award Levels 1 and 2: https://cdmrp.army.mil/funding/pa/FY20-BCRP-BTA12-2.pdf
Era of Hope Scholar Award: https://cdmrp.army.mil/funding/pa/FY20-BCRP-EOHS-2.pdf The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the “best and brightest” in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research. As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention Interested in applying? Email Uli and Brittany to let them know. |
Breakthrough: Level 1: US$450k - 750k Level 2: US$1.5-2M
Era of Hope: up to US$3M total
|
LoI: 11 March 2021
|
full application if invited: March 25 - June 23 2021 depending on level
|
USDoD |
Duchenne Muscular Dystrophy Research ProgramIdea Development Award: https://cdmrp.army.mil/funding/pa/FY20-DMDRP-IDA.pdf All applications for the FY20 DMDRP Idea Development Award (IDA) must address opportunities and challenges in the development of safe and effective macromolecular and cellular therapies that address primary pathology of DMD. Eligible therapeutic strategies include: gene therapy, genome editing, oligonucleotide therapies, exon skipping, protein therapeutics, and cell therapies. Therapies that will be efficacious across the life-span, particularly in adolescents and adults are encouraged Interested in applying? Email Uli and Brittany to let them know. |
up to US$350k |
|
|
US DoD |
Neurotoxin Exposure Treatment Parkinson's Research ProgramThe vision of the NETP Program is to eliminate Parkinson’s disease through neurotoxin exposure and treatment-related research in partnership with scientists and consumers.The NETP Program invests in scientific research to better understand and treat the neuro-degenerative effects of PD associated with military deployment and environmental and/or occupational exposures. Research into military service-related risk factors is critical for past, present, and future Service members who may be affected by PD. Focus areas include:
A summary of award mechanisms (ECR / professor level) can be found here: https://cdmrp.army.mil/funding/pdf/20netpreftable.pdf Interested in applying? Email Uli and Brittany to let them know. |
Parkinsons ECR (<10 years post PhD): up to US$400k for up to 2 years |
|
|
MND Australia |
Innovator grants MND researchers working in Australia in applied research or fields relevant to the cause, treatment or cure of MND. Applicants must be Australian citizens or have permanent resident status.
The Betty and John Laidlaw MND Research Prize The Betty and John Laidlaw MND Research Prize aims to reward an outstanding *mid-career researcher with a demonstrated background of excellence in neuroscience research. The Prize is for an innovative 2-year project to advance the understanding of **classical MND with a clear potential for effective treatments. It aims to support research commencing in the calendar year 2021. For more info about both see: https://www.mndaust.asn.au/Discover-our-research/grants-and-research-meetings/Apply-for-a-grant.aspx Interested in applying? Email Uli and Brittany to let them know. |
Innovator: Up to $100k One year Betty and John Laidlaw MND Research Prize mid-career researchers: 5-12 years post PhD up to $200 for up to 2 years |
August
|
|
Dementia Australia Research Foundation |
Project grants https://www.dementia.org.au/research/grants The Dementia Australia Research Foundation Project Grants are open to Australian-based dementia researchers undertaking projects across all forms of dementia and in any topic area; biomedical (lab-based), clinical, psychosocial, or knowledge translation research projects will be considered.
World Class Research Projects The Dementia Centre for Research Collaboration (DCRC) is pleased to announce the following grant round to fund World Class Research Projects including trials and studies to produce evidence, evaluate interventions, promote practice change or inform policy Interested in applying? Email Uli and Brittany to let them know. |
up to $75k pa Early and mid- career researchers (i.e. level A, B and C only)
max $600k per grant
|
August | |
MTPConnect |
MTPConnect is a not-for-profit organisation which aims to accelerate the rate of growth of the medical technologies, biotechnologies and pharmaceuticals sector to achieve greater commercialisation and establish Australia as an Asia-Pacific hub for MTP companies. It was formed in November 2015 as part of the Federal Government’s Industry Growth Centres Initiative. They operate several initiatives: The Biomedical Translation Bridge program aims to nurture early stage health and medical research ventures to reach proof-of-concept stage with potential to attract further capital and support. EOIs need to clearly articulate clinical benefit to patients and an advantageous point of differentiation from anything similar on the market or in development. The Biomedical Translation Bridge program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage. The Australian Government's $45 million BioMedTech Horizons is an initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential. Investments from the program will be focused on supporting cutting-edge ideas towards proof-of-concept and commercialisation. Head to the BioMedTech Horizons page for more details. MTPConnect is charged with driving innovation and growth in the medical technology, biotechnology and pharmaceutical sector. With the sector on the cusp of realising it’s full commercial potential, MTPConnect is kickstarting collaborative, industry-led projects through a dollar-for-dollar matched Project Fund Program. We are looking for consortia large and small to creatively address some of the barriers to growth, as outlined in our 10-year Sector Competitiveness Plan, to share in a funding pool of $15.6 million. Head to the Project Fund Program page for more details. Interested in applying? Email Uli and Brittany to let them know. |
generally up to $1 million of matching funding over a period of up to two years. |
normally various times throughout the year
currently - no information about new rounds available |
|
NIH
|
NIH have their own search engine for grant opportunities: https://grants.nih.gov/funding/searchguide/index.html#/ Examples are: Notice of Special Interest: Selective Cell and Network Vulnerability in Aging and Alzheimer’s DiseaseAreas of research interest and opportunity include, but are not limited to, the following:
For more information please see: https://grants.nih.gov/grants/guide/notice-files/NOT-AG-19-033.html
Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution (NOT-ES-20-018):This Trans-NIH partnership seeks to support research to gain comprehensive understanding of the biology of the resolution of inflammation to elucidate the critical distinctions between resolution and anti-inflammatory mechanisms. For more information please see: https://grants.nih.gov/grants/guide/notice-files/NOT-ES-20-018.html
Notice of Special Interest (NOSI): Sleep and Substance Use Disorders (NOT-DA-20-021)The purpose of this noticeis to inform potential applicants to the National Institute on Drug Abuse (NIDA) about a special interest in research project applications focusing on the relationship between processes that regulate sleep/circadian rhythm and the risk, trajectory and treatment of substance use disorders. Identifying sleep/circadian mechanisms and determining the directionality of sleep and substance use disorder interactions addresses a knowledge gap and can present new opportunities for improved therapy and outcomes. Multi-disciplinary, multiple-investigator teams of researchers combining expertise in substance use disorders and mechanisms of sleep/circadian rhythms would be optimal in addressing these questions. For more information please see: https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-021.html
Notice of Special Interest: Alcohol and Cancer Control: NOT-CA-20-034This Notice highlights interest in receiving investigator-initiated grant applications addressing the effects of alcohol on human health across the cancer control continuum. For more information see: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-034.html
Notice of Special Interest (NOSI): Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk: NOT-CA-20-002The purpose of this Notice of Special Interest (NOSI) is to inform potential applicants to the National Cancer Institute (NCI) of special interest to promote research that incorporates biological information within population-based cancer epidemiologic studies to identify and understand how the interplay between environmental exposures (e.g., chemical and physical exposures, dietary, and other exposures) and germline genetic variation contribute to cancer risk. Biological information can include functional annotations of the genome (e.g., methylation, promoters or enhancers); methods of linking variants to genes (e.g., expression quantitative trait loci analysis), gene pathway or network-based approaches (e.g., network modeling); analysis of metabolites or biomarkers, or data from mechanistic studies. For more information see: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-002.html
Notice of Special Interest: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain NOT-HD-19-020Successful pain management (and prevention) necessitate a better understanding of how sleep disturbances (and their associated biological mechanisms) contribute to chronic pain, including its transition from acute pain. It is likely that chronic pain prevention and treatment can be more effective with explicit integration of sleep (and mental health). For more information see: https://grants.nih.gov/grants/guide/notice-files/NOT-HD-19-020.html
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) PAR-19-305This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging and/or multiple chronic conditions in older people (e.g., sarcopenia, heart failure with preserved ejection fraction (HFpEF), immunosenescence, metabolic syndrome, chronic kidney disease). This includes the development of pharmacological strategies such as new classes of compounds (e.g., senolytics, anti-inflammatory agents, modulators of proteostasis and autophagy), natural products (or their derivatives, mimics, and synthetic equivalents), biologics, stem/progenitor cell-based therapies, and the repurposing of Food and Drug Administration (FDA)-approved drugs. For more information see: https://grants.nih.gov/grants/guide/pa-files/PAR-19-305.html
Interested in applying? Email Uli and Brittany to let them know. |
R01: NIH Research Project Grant Program supports specific research projects over 3-5 years. There is no funding limit. R03: NIH small grant program - 2 years of funding up to USD $50k per year R21: Exploratory / Developmental Research Grant Award supports early stages of project development and novel ideas that come with risk. Funding is limited to two years and USD $275k |
Commencing in August, McAllister & Quinn (M&Q) will deliver two 1-hour training webinars providing an overview of the NIH and how to craft a competitive NIH proposal. Researchers interested in receiving tailored feedback and one-on-one coaching from M&Q can then submit a draft concept paper to UQ R&I, with up to eight UQ researchers selected to participate in the full training program, working with M&Q and the Office of Sponsored Research (OSR) to develop an NIH solicitation response. The expected minimum time commitment for the complete training program is 8-15 hours over 14 weeks. Health sciences researchers interested in submitting a proposal for NIH funding in 2020/2021 are invited to submit an NOI to RSVP for this training program. NOIs close with the UQ R&I International Grants team (internationalgrants@research.uq.edu.au) on Tuesday 18 August 2020
Training program:Webinar #1: Introduction to U.S. Federal Research Funding in the Health and Biomedical Sciences – 19 August 2020, 9:30 – 10:30am Webinar #2: Best Practices for Crafting a Competitive Submission to the National Institutes of Health – 9 September, 9:30 – 10:30am Following the first Webinar, interested researchers are invited to complete a draft concept paper for consideration by OSR and M&Q. Up to eight UQ researchers will then be selected to participate in the full training program.
|
standard due dates are: R01 - 5 February, 5 June, 5 October R03 - 16 February, 16 June, 16 October R21 - 16 February, 16 June, 16 October
NOT-ES-20-018: open October 2020 through to May 31, 2024
NOT-DA-20-021: open until 8/9/2023
NOT-CA-20-034: open now until 9/9/23
NOT-CA-20-002: open until 8/1/22
NOT-HD-19-020: open until 8/9/22
PAR-19-305: open until 17/7/22 |
Muscular dystrophy association (MDA) |
MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular diseases. We do this through innovations in science and innovations in care. As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases. In addition to the work MDA does to provide the best clinical care and support to families living with neuromuscular disease, funding the most promising and innovative research is a top priority. DA provides support for research throughout the pipeline of drug development from discovery research through clinical trials. Funding opportunities exist for both academic investigators as well as for biotech and pharma seeking to develop therapies for neuromuscular disease. MDA offer a variety of funding opportunities: Discovery research: Research grants and Development grants Tranlsational Research: MDA Venture Philanthropy Program Clinical Research: Clinical Research Grants and Clinical Research Network Grants For more information see: https://www.mda.org/science/funding-opportunities |
Research grants: $100k pa for up to 3 years Tranlsational grants: 2-3 years R&D up to US$300k Preclinical (up to US$500k) Early clinical (Phase 1/2: up to US$1M) Clinical Research up to 3 years, up to US$500k and US$1M for network grants
|
Paused due to COVID | |
RIVKIN Centre |
Ovarian Cancer Research grants: Pilot study Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered.
For more info see: https://rivkin.org/wp-content/uploads/2019/12/Rivkin-Pilot-Study-Award-Guidelines-rev-08-19-for-2020.pdf
|
1 year US$75k |
submission through proposal Central | December |
Brightfocus |
https://www.brightfocus.org/grants/types-grants Alzheimer's DIseases Research Program: BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer's disease. The goal of the program is to accelerate our understanding of the biological mechanisms underlying Alzheimer’s Disease and related dementias as well as innovative approaches to better diagnose, prevent or delay the progress of the disease. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Typically, these awards are made to early stage investigators, or to more established investigators who are proposing particularly innovative research. Interested in applying? Email Uli and Brittany to let them know. |
$300,000 for 3 years | November | |
|
|
|
||
|